The U.S. CDC (Centers for Disease Control and Prevention) expanded coronavirus booster dose eligibility for some youngsters to fight the highly infectious Omicron variant of SARS-CoV-2. The action comes as the U.S. public health agency experiences criticism over confusing...
According to FlightAware, a U.S. multi-national aviation company, 4529 flights globally had been canceled by late Sunday, with over 2600 journeys canceled within, into, or out of America. Another 4519 American flights were delayed Sunday, 2 January 2022, according...
On Monday, the U.S. CDC (Centers for Disease Control and Prevention) cut the recommended isolation times when they’ve tested coronavirus-positive from ten-days to five-days if they do not have virus symptoms – and if they use face masks around...
The United Kingdom reported over 93045 in the country had tested coronavirus-positive in 24-hours, the 3rd consecutive day that the U.K.’s case tally set a record, health officials announced Dec. 17, as the fast-transmitting Omicron variant puts pressure on...
On Wednesday, the United States Food and Drug Administration (FDA) approved the use of synthetic antibodies produced by a British-Swedish pharmaceutical and biotechnology company AstraZeneca for long-term prevention of COVID-19 among immunocompromised people before they’ve been exposed to the...
On Thursday, Joe Biden, the United States President, has unveiled stringent COVID-19 travel restrictions as America confirmed a few Omicron cases have been found in Colorado, California, Hawaii, Minnesota, and New York, where officials say person had no recent...
On Wednesday, Moderna Therapeutics President Stephan Hoge said coronavirus booster doses targeting the Omicron variant could be ready to file for United States approval by March 2022. However, Dr. Anthony Fauci, President Biden’s Chief Medical Advisor, and Moderna executive...
Dr. Francis Collins, Director of the National Institutes of Health, says the new Omicron variant of COVID-19 might prompt a return to stringent COVID measures if not a sufficient number of people get inoculated or boosted.
Cases of the new...
A team of infectious disease advisers to the U.S. Food and Drug Administration (FDA) will look at outcomes of Merck and Ridgeback Biotherapeutics’ clinical trial and decide whether to recommend Emergency-Use-Authorization (EUA) for molnupiravir pill to treat early-stage coronavirus...
On Monday, Kamala Devi Harris, the Vice President of the United States of America, declared that the President Joe Biden government is investing 1.5 Bn dollars from the COVID-19 relief package to address the healthcare employee’s shortage in underscored...
